← Back to all trials
Recruiting
NCT07390240
The Effect of Monoallelic Variants in the ALPL Gene on the Natural Course of Hypophosphatasia in Russia
Conditions: Hypophosphatasia
Sex: All
Healthy volunteers: No
Enrollment: 55
Sponsor: AstraZeneca
Location: Research site Moscow
Summary
The effect of monoallelic variants in the ALPL gene on the natural course of hypophosphatasia (HPP) in children and adults in Russia (ATLANTIS)
Eligibility Criteria
Inclusion criteria:
1. Age ≥4 to \
Source: ClinicalTrials.gov (NCT07390240). StuddyBuddy aggregates publicly available trial information.